Besvil Trio 100 is a combination inhaler used for the long-term management of Chronic Obstructive Pulmonary Disease (COPD). It contains three active ingredients such as Fluticasone furoate a corticosteroid that helps reduce inflammation in the lungs, Umeclidinium a long-acting muscarinic antagonist (LAMA) that helps relax and open the airways and Vilanterol a long-acting beta-agonist (LABA) that works by improving airflow by relaxing the airway muscles.
This combination therapy is designed to reduce COPD symptoms, manage flare-ups, and improve lung function over time, making it ideal for individuals with moderate to severe COPD. For optimal results, patients should use the inhaler once daily, typically at the same time each day, to ensure consistent symptom control. It is important to follow the prescribed dosage and ensure proper inhaler technique to maximize the efficacy of the medication.
When using Besvil Trio 100, it is important to adhere to precautions and directions for use. The inhaler should be used as prescribed. Do not exceed the recommended dose to avoid the risk of side effects such as increased heart rate or potential lung infections. Patients should avoid using Besvil Trio 100 if they are allergic to any of its components.
Close monitoring of potassium levels and blood sugar is advised especially for those with a history of diabetes or electrolyte imbalance. Pregnant and breastfeeding women should consult their healthcare provider before starting the medication, as the effects of Besvil Trio 100 during pregnancy are not well-studied.
The common side effects of Besvil Trio 100 include upper respiratory infections, pneumonia, oral thrush, headache, back pain, and bronchitis. While these side effects are generally mild, patients should contact their healthcare provider if they experience symptoms such as wheezing, chest pain or difficulty breathing.
Besvil Trio 100 is not recommended for use in children due to insufficient safety data, and...
No content available
